Method for large-scale enrichment of RNA binding protein in mammalian tissue and identification method of RNA binding protein

Through dual cross-linking tandem thiol-alkynyl click chemical reaction and formaldehyde cross-linking, combined with 254nm ultraviolet cross-linking, in situ cross-linking of RNA-protein interactions and large-scale enrichment of RBPs in mammalian tissues, solving the problem of The problem of specific capture and identification of RNA-protein interactions in the prior art improves the accuracy and specificity of identification.

CN119000210APending Publication Date: 2024-11-22EXPERIMENTAL RES CENT CHINA ACAD OF CHINESE MEDICAL SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411113314.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to cross-link in situ and specifically capture the dynamic interaction between RNA and proteins in mammalian tissues, especially non-coding RNA-binding proteins, and cannot distinguish directly and indirectly bound proteins, affecting the reality of RNA-protein interactions. Reflect and scale identification of RBPs.

Method used

Using a dual cross-linked tandem thiol-alkynyl click chemical reaction, alkyne modified RNA is introduced through metabolic labeling, combining formaldehyde cross-linking and 254nm ultraviolet cross-linking, and RNA is achieved by using the high membrane permeability of formaldehyde and the instability of cross-linking to achieve RNA. Specific cross-linking and enrichment with proteins, excluding interference from DNA/protein-protein complexes, enrichment and SDS-PAGE analysis were performed using streptavidin magnetic beads.

Benefits of technology

Realize the true reflection of RNA-protein interactions in mammalian tissues and the large-scale enrichment identification of RBPs, improve the specificity and accuracy of RNA-protein interactions, and overcome the low selectivity and ultraviolet in the prior art. The problem of insufficient penetration of light.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119000210A_ABST
    Figure CN119000210A_ABST
Patent Text Reader

Abstract

The invention provides a method for enriching RNA (Ribonucleic Acid) binding protein in mammalian tissues on a large scale and an identification method of the RNA binding protein, and belongs to the technical field of biology. The method comprises the following steps: introducing alkyne modification on RNA (Ribonucleic Acid) of a mammal in a metabolic labeling manner; sequentially carrying out in-situ PBS (Phosphate Buffer Solution) and formaldehyde perfusion on the alkyne modified mouse; closing free sulfydryl, and performing biotinylation labeling on the RNA on the basis of sulfydryl-alkynyl click chemical reaction after tissue lysis, so as to obtain biotin labeled RNA; the method comprises the following steps: carrying out specific crosslinking on biotin labeled RNA and RBPs by using 254nm ultraviolet rays, and fixing RNPs; raising the temperature to decrosslink the formaldehyde; carrying out enrichment and elution to obtain an enriched product RBPs; and carrying out SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) and mass spectrometry on the enriched product RBPs. The method can be used for comprehensively and systematically characterizing the RNA-protein interaction in mammalian tissues.
Need to check novelty before this filing date? Find Prior Art